Evidence map›Paper›PMID 28247605›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2016

[Efficacy of adjuvant endocrine therapy in breast cancer patients with a positive-to-negative switch of hormone receptor status after neoadjuvant chemotherapy].

Guangfa Xia, Juanying Zhu, Jun Yuan, Bo Cao, Jie Tang, Yiding Chen

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Guangfa XiaDepartment of Surgical Oncology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China; Department of Breast Surgery, Jiaxing Maternity and Child Health Care Hospital, Jiaxing 314000, China.
Juanying ZhuDepartment of Breast Surgery, Jiaxing Maternity and Child Health Care Hospital, Jiaxing 314000, China.
Jun YuanDepartment of Breast Surgery, Jiaxing Maternity and Child Health Care Hospital, Jiaxing 314000, China.
Bo CaoDepartment of Breast Surgery, Jiaxing Maternity and Child Health Care Hospital, Jiaxing 314000, China.
Jie TangDepartment of Breast Surgery, Jiaxing Maternity and Child Health Care Hospital, Jiaxing 314000, China.
Yiding ChenDepartment of Surgical Oncology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China. ydchen@zju.edu.cn.
First Hospital of Jiaxing · CNJiaxing University · CNSecond Affiliated Hospital of Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, HormonalAxillaBreast NeoplasmsChemotherapy, AdjuvantDisease-Free SurvivalErb-b2 Receptor Tyrosine KinasesFemaleHumansKaplan-Meier EstimateLymphatic MetastasisLymph NodesMiddle AgedNeoadjuvant TherapyNeoplasms, Hormone-DependentNeoplasm StagingProportional Hazards ModelsAntineoplastic Agents, HormonalERBB2 protein, humanErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID28247605
PMCPMC10396897
OpenAlexW3010707456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.